Long-term efficacy of bezafibrate in reduction of small, dense low-density lipoprotein by hypotriglyceridemic action

Grundy, 1998, Primary prevention of coronary heart disease: Guidance from Framingham: A statement for healthcare professionals from the AHA Task Force on Risk Reduction. American Heart Association, Circulation, 97, 1876, 10.1161/01.CIR.97.18.1876 Lamarche, 1996, Triglycerides and HDL-cholesterol as risk factors for ischemic heart disease. Results from the Quebec Cardiovascular Study, Atherosclerosis, 119, 235, 10.1016/0021-9150(95)05653-X Lamarche, 1997, Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men. Prospective results from the Quebec Cardiovascular Study, Circulation, 95, 69, 10.1161/01.CIR.95.1.69 McNamara, 1992, Change in LDL particle size is associated with change in plasma triglyceride concentration, Arterioscler Thromb, 12, 1284, 10.1161/01.ATV.12.11.1284 Coresh, 1993, Association of plasma triglyceride concentration and LDL particle diameter, density, and chemical composition with premature coronary artery disease in men and women, J Lipid Res, 34, 1687, 10.1016/S0022-2275(20)35731-X Katzel, 1994, Relations of plasma TG and HDL-C concentrations to body composition and plasma insulin levels are altered in men with small LDL particles, Arterioscler Thromb, 14, 1121, 10.1161/01.ATV.14.7.1121 Yoshida, 1998, Beneficial effect of gemfibrozil on the chemical composition and oxidative susceptibility of low density lipoprotein: A randomized, double-blind, placebo-controlled study, Atherosclerosis, 139, 179, 10.1016/S0021-9150(98)00062-8 Guerin, 1996, Fenofibrate reduces plasma cholesteryl ester transfer from HDL to VLDL and normalizes the atherogenic, dense LDL profile in combined hyperlipidemia, Arterioscler Thromb Vasc Biol, 16, 763, 10.1161/01.ATV.16.6.763 Toyota, 1999, Low density lipoprotein (LDL) binding affinity for the LDL receptor in hyperlipoproteinemia, Atherosclerosis, 147, 77, 10.1016/S0021-9150(99)00166-5 Ruotolo, 1998, J Am Coll Cardiol, 32, 1648, 10.1016/S0735-1097(98)00442-2 Freidewald, 1972, Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge, Clin Chem, 18, 499, 10.1093/clinchem/18.6.499 Nichols, 1986, Nondenaturing polyacrylamide gradient gel electrophoresis, Methods Enzymol, 128, 417, 10.1016/0076-6879(86)28084-2 Hirano, 1996, High prevalence of small LDL particles in non-insulin-dependent diabetic patients with nephropathy, Atherosclerosis, 123, 57, 10.1016/0021-9150(95)05772-2 Hirano, 1998, High prevalence of small dense LDL in diabetic nephropathy is not directly associated with kidney damage: A possible role of postprandial lipemia, Atherosclerosis, 141, 77, 10.1016/S0021-9150(98)00150-6 Fruchart, 1999, Peroxisome proliferator-activated receptor-alpha activators regulate genes governing lipoprotein metabolism, vascular inflammation and atherosclerosis, Curr Opin Lipidol, 10, 245, 10.1097/00041433-199906000-00007 Deckelbaum, 1984, Plasma triglyceride determines structure-composition in low and high density lipoproteins, Arteriosclerosis, 4, 225, 10.1161/01.ATV.4.3.225 Griffin, 1994, Role of plasma triglyceride in the regulation of plasma low density lipoprotein (LDL) subfractions: Relative contribution of small, dense LDL to coronary heart disease risk, Atherosclerosis, 106, 241, 10.1016/0021-9150(94)90129-5 Karpe, 1993, Composition of human low density lipoprotein: Effects of postprandial triglyceride-rich lipoproteins, lipoprotein lipase, hepatic lipase and cholesteryl ester transfer protein, Atherosclerosis, 98, 33, 10.1016/0021-9150(93)90221-F Weintraub, 1998, Effects of fibric acid derivatives and metformin on postprandial lipemia, Atherosclerosis, 141, S71, 10.1016/S0021-9150(98)00221-4